Non-interventional Study on Quality of Life, Efficacy and Tolerability of Nab-paclitaxel/Gemcitabine Firstline Therapy in Patients With Metastatic Pancreatic Cancer
Phase of Trial: Phase IV
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms QoliXane
- 12 Sep 2017 Interim efficacy results (n=539) presented at the 42nd European Society for Medical Oncology Congress.
- 11 Oct 2016 Interim results (n=25) presented at the 41st European Society for Medical Oncology Congress.
- 15 Aug 2016 Planned End Date changed from 1 Oct 2017 to 1 May 2018.